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Human immunodeficiency virus reverse transcriptase (HIV-RT) binds more stably in 
binary complexes with RNA–DNA versus DNA–DNA.  Current results indicate that 
only the -2 and -4 RNA nucleotides (-1 hybridized to the 3´ recessed DNA base) are 
required for stable binding to RNA–DNA, and even a single RNA nucleotide 
conferred significantly greater stability than DNA–DNA.  Replacing 2´- hydroxyls on 
pivotal RNA bases with 2´-O-methyls did not affect stability, indicating that 
interactions between hydroxyls and RT amino acids do not stabilize binding.  Avian 
myeloblastosis and Moloney murine leukemia virus RTs also bound more stably to 
RNA–DNA, but the difference was less pronounced than with HIV-RT.  We propose 
that the H- versus B-form structures of RNA–DNA and DNA–DNA, respectively, 
allow the former to conform more easily to HIV-RT’s binding cleft, leading to more 
stable binding.  Biologically, this may aid in degradation of RNA fragments that 
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1.1 Structural and Genetic Properties of HIV-1 
 At 120 nm in diameter and with a genome approximately 9.3 kb in size, HIV-
1 is structurally distinct from other members of the Retroviridae family to which it 
belongs (30).  Though this is the case, it shares many common morphological and 
biological features with other members of the lentiviral genus, a group of viruses 
commonly associated with long-duration illnesses and prolonged periods of viral 
latency, such as a spheroid, enveloped structure and the possession of two copies of a 






























Both the envelope proteins, as well as the structural and enzymatic proteins necessary 
for replication, integration, etc. are derived from this genome, which is composed 
primarily of the env, gag, and pol genes.  In total, 15 distinct proteins are generated, 
largely via splicing of the full-length genomic mRNA.  These proteins and their 
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Figure 2. Schematic representation of the HIV-1 genome; adapted from 
http://www.mimo.unige. ch/images/Genome.jpg.  HIV-1 proteins and their functions are 






















It is also through proper transmission and replication of this genome that HIV-1 
infection occurs.  
 
1.2 Life Cycle of HIV-1 in the Host 
 In order for entry to occur, the HIV-1 surface glycoprotein, gp120, must 
interact with CD4 receptors on the surface of immune cells such as T cells and 
macrophages, the primary targets of HIV-1 infection.  In addition to CD4 receptor 
binding, successful entry is dependent upon interaction of gp120 with co-receptors on 
the cell surface.  The receptors commonly used for HIV entry are CCR5 (R5) and 
CXCR4 (X4), with the R5 and X4 moieties typically found on macrophages and T 
cells, respectively (12).  
Once the virus enters the host cell, it uncoats and releases its contents into the 
cytoplasm (see Figure 3).  It is here that the process of reverse transcription occurs.  
Reverse transcription, which is common to Retroviridae as well as select other viral 
and non-viral species (for instance, the Saccharomyces Cerevisiae Ty3 
retrotransposon), involves conversion of single-stranded genomic RNA into a double-
stranded DNA, which is subsequently transported to the host cell nucleus and 
integrated into the host genome.  A more through description of this process can be 














The process of integration itself is facilitated by the enzyme integrase, which 
begins by cleaving two nucleotides from the 3′ ends of both DNA strands, exposing 
the 3′- hydroxyl group on the terminal CA dinucleotide that is conserved among 
retroviruses and many transposons (15).  The modified double-stranded DNA is then 
inserted into the target DNA sequence, and the host cell machinery is employed to 
ligate the sequence into place.  While integration can potentially occur anywhere 
throughout the host genome, HIV-1 has been noted to exhibit a preference for 
integrating near sites of active gene transcription (15). 
When the host cell divides, the newly integrated DNA is “read”1 and RNA 
polymerase II carries out transcription, resulting in the production of viral RNA 
which, in the case of HIV-1, is subjected to the same processing steps as cellular 
mRNAs, including: a) 5′ capping; b) 3′ polyadenylation; c) splicing; etc.  As partially 
illustrated in figure 2 above, RNAs are then utilized primarily to either act as the new 
viral genome or to encode the various proteins required for replication, viral 
maintenance, and virulence.   
These proteins, which are detailed also in Figure 2, are synthesized externally 
of the nucleus and are largely derived from the proteolytic cleavage of the Gag-Pol 
and env polyproteins by viral protease or by cellular proteases, respectively (32).  
Proper maintenance of the ratio of the Gag and Pol proteins is critical for RNA 
dimerization and virion infectivity and is regulated by a -1 frameshifting event that 
                                                
1 Note that it is the viral long terminal repeats (LTRs) that act as promoters for 
transcription of HIV-1. 
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occurs due to the presence of a “slippery” sequence in the HIV-1 genome that allows 
for read-through of a stop codon at the end of the gag gene (66). 
Following protein production, and during the final stages of viriogenesis, the 
complement of structural and enzymatic proteins necessary for the formation of a 
new, intact virus assemble at the surface of the host cell.  This event is orchestrated 
largely by the association of Gag/Gag-Pol with viral genomic RNA dimers via the 
nucleocapsid portion of the precursor and by localization of Env proteins to the 
assembly site—a step that, in turn, causes migration of Gag-Pol/RNA constructs to 
the assembly site as well. Multimerization of Gag, along with interaction of a series of 
host proteins, leads to a curvature at the assembly site, allowing the new virion to bud 
and release (18).  Protein maturation in the virion, which is thought to begin as early 
as during the late stages of assembly, is carried out by the viral protease and involves 
the cleavage of polyproteins into their active forms.  The mature virus is then capable 
of infecting subsequent host cells. 
 
1.3 Epidemiological Aspects of Acquired Immunodeficiency Virus (AIDS) and 
Therapeutic and Preventative Measures Against HIV-1 Infection 
From an epidemiological standpoint, reports estimate that more than 30 
million people are currently living with HIV-1 infection worldwide, with the largest 
fraction of these individuals residing in sub-Saharan Africa (13).  In this region, as 
well as North America and Eurasia, protective measures—such as male circumcision, 
sexual education and condom usage—have generated both an awareness of and 
10 
understanding towards the HIV-1 associated Acquired Immunodeficiency Syndrome 
(AIDS) and the impact of this disease on society (13, 60).  While this is the case, the 
relatively high levels of recombination and genetic variation common to HIV-1 act as 
confounding factors in the development of an “ultimate” preventative which could 
potentially eradicate the disease.   
HIV-1 is classified into three groups: M, N and O (main, new and outlier, 
respectively).  Of these groups, M is comprised of a diversity of subtypes and is 
responsible for nearly 90% of all HIV-1 infections worldwide (44; Figure 4).  
Furthermore, the prevalence of a number of circulating recombinant forms, which are 
generated through intersubtype recombination, act to create additional diversity in 
regions such as Africa, South America, and Asia.  Circulating recombinant form 
CRF01_AE has, for instant, been shown to constitute over 3% of total HIV infections 
worldwide (57). 























As indicated previously, several anti-retroviral drug regiments and 
therapeutics have been developed in an effort to curtail the incidence of infection, the 
most common of which is Highly Active Antiretroviral Therapy (HAART).  In light 
of increased genetic diversity of the virus, and therefore an increased potential for 
emergence of drug resistant subtypes, patients undergoing HAART are typically 
prescribed a cocktail of three or more drugs (10).  The major classes of antiretrovirals 




















Table 1. Major classes of antiretroviral drugs 
DRUG CLASS DESCRIPTION/FUNCTION EXAMPLE 
Nucleoside Reverse 
Transcriptase Inhibitors 
Mimic nucleosides and act as 
“chain terminators” once 




Bind near RT active site, 
inhibiting polymerization 
Nevarapine 
Entry Inhibitors Act to inhibit HIV-1 
glycoproteins gp120 and gp41 
from interacting with receptors 
on the host cell surface 
Enfuviritide 
Protease Inhibitors Blocks protease, which is 
responsible for proteolytic 
cleavage of polyproteins 
Ritonavir 
Integrase Inhibitors Prevents integration of viral 















In addition to drug therapy, several studies have implicated the use of siRNA 
(small inhibitory RNA) and alternative natural products, such as alkaloids and 
flavonoids, as potentially viable means of treatment (6, 42; respectively).  Vaccine 
development has also been proposed and tested, though given the extreme diversity of 
the virus, an effective vaccine has not yet been produced and there is no guarantee that 
such a vaccine can be developed in the future (3).  For this reason, among others, it is 
imperative that individuals be exposed to and educated about the various preventative 

























Chapter 2: Analysis of Those Requirements Necessary and 
Sufficient for Tighter Binding of HIV-1 Reverse Transcriptase 








 2.1.1 The General Mechanism of HIV-1 Replication 
 Retroviruses, such as HIV-1, are unique among other positive-stranded RNA 
viruses in that they utilize the process of reverse transcription to convert their 
genomic RNA into double-stranded, proviral DNA.  This process is achieved largely 
by the multifunctional reverse transcriptase, which possesses both RNA/DNA-
dependent, DNA polymerization and RNase H functions (1, 14, 44).  While such a 
description may paint a relatively simplistic view of this mechanism, it is important to 
note that reverse transcription is, in fact, a complex, multistep process.  
In the case of HIV-1, reverse transcription initiates from the 3´OH of a 
cellular tRNALys, 3 that is hybridized to the primer-binding site (PBS) within the viral 
RNA genome, and extension of the tRNA primer to the 5´ terminal repeat (R) occurs 
via RNA-dependent DNA polymerization (Figure 5; 63).  This extension product is 







Figure 5. Schematic Representation of Reverse Transcription in HIV-1.  (A) Minus strand 
synthesis (DNA strand in red) is initiated using a cellular tRNA annealed to the PBS.  The 
RNA strand of the RNA:DNA hybrid is degraded by RNase H of HIV-RT.  (B) First strand 
transfer event in which the newly formed DNA anneals to the 3´ end of the viral genome.  (C) 
Minus strand DNA synthesis resumes and complimentary RNA (PPT withstanding) is 
degraded.  (D) PPT is used as a primer for second strand DNA synthesis.  (E) RNase H 
removes the tRNA and PPT.  (F) Completion of second strand synthesis results in the 





Following this step, RNase H digestion of the RNA portion (represented as a 
dotted line in part A of the above figure) of the newly created RNA-DNA hybrid 
region occurs, allowing for hybridization of both the minus-strand intermediate and 
viral genomic RNA 3’ R regions (as seen in panel B).  Once this first strand transfer 
event occurs, elongation of the nascent DNA and degradation of the complementary 
RNA proceeds in a similar fashion as previously described, though the hydrolysis-
resistant polypurine tract (PPT) remains intact.  This is critical, as subsequent second-
strand DNA synthesis is dependent upon the PPT as a primer (14, 34).  Upon 
completion of DNA synthesis, RNase H degrades both the tRNA primer and the PPT 
(see panel E), allowing for the second strand transfer event to occur via the 
interaction of the two, complementary PBS regions.  This interaction signals for the 
completion of double-stranded DNA (dsDNA) synthesis via DNA-dependent DNA 
polymerization.  The remaining dsDNA, with its long terminal repeat (LTR; see panel 
F) regions intact, is then ready to be processed by the downstream integrase protein 
for insertion into the host genome (12, 14). 
 
2.1.2 Human Immunodeficiency Virus-1 Reverse Transcriptase (HIV-RT) 
 In addition to its role in replication, as detailed above, crystallographic data on 
HIV-RT has provided the first structural views of retroviral reverse transcriptases 
(RTs).  As this data illustrates, the p66 catalytic subunit of the heterodimeric HIV-1 
reverse transcriptase, like many other polymerases, resembles a right-handed 
structure whose subdomains have, appropriately, been identified as the palm, thumb 
and fingers (see Figure 6; 52).  Mutational analysis of heterodimers has indicated that 
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both the polymerase and RNase H activities of the enzyme reside on the p66 subunit, 
















































































  Figure 6. Schematic representation of HIV-1 Reverse Transcriptase indicating both the 
  polymerase active site and RNase H domains of the enzyme.  “Right-handed” structure of 










In addition to studying the structure of HIV-RT, extensive research has been 
conducted on the interaction of HIV-1 reverse transcriptase with various RNA and 
DNA substrates.  Generally, such studies (9, 21, 26, 69) have indicated a higher 
binding affinity of HIV-RT to RNA vs. DNA templates, possibly due to increased 
interactions of RT amino acids with 2´-OH groups of RNA nucleotides and a higher 
degree of steric flexibility in RNA vs. DNA substrates.  A more comprehensive 
review of this literature is presented in section 2.1.3 below. 
 
 2.1.3 Binding of HIV-RT to DNA and RNA Templates 
 During HIV-1 replication, the role of its reverse transcriptase (HIV-RT) in 
binding both DNA and RNA substrates is critical, ultimately, for the production of 
double stranded viral DNA that can be integrated into the host genome.  As 
mentioned previously, this process is largely achieved as a result of the 
multifunctional nature of the polymerase, specifically its ability to synthesize DNA as 
both a DNA- and RNA-dependent DNA polymerase, as well as its possession of an 
RNase H active site, which is critical for degradation of RNA regions of DNA-RNA 
hybrids (5, 44, 72). 
Several studies have provided a more comprehensive examination of the 
interaction of HIV-RT with DNA and RNA substrates, concluding, among other 
findings, that the binding stability of the polymerase to RNA-DNA hybrids is much 
tighter than that of DNA-DNA or RNA-RNA duplexes (33, 37, 20, 21, 69, 81).  It has 
been proposed that this phenomena is due, at least in part, to the numerous additional 
contacts HIV-RT makes with DNA-RNA primer-template hybrids and, more 
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specifically, with 2´-hydroxyl groups on the RNA nucleotide itself (3, 63).  While this 
is the case, contacts with 2´-hydroxyl groups account for only a fraction of such 
interactions, suggesting that alternative explanations for the slower dissociation of RT 
from RNA-DNA substrates may exist (26, 69).  For instance, DNA-DNA and RNA-
DNA hybrids are known to take on different structures, with the former generally 
being B-form and the latter being H-form (hybrid form), an intermediate between A- 
(the form taken by most RNA-RNA hybrids) and B-form (11).  These different 
structures could also possess a putative role in binding.    
To better define the requirements for tighter binding of HIV-RT to RNA-
DNA vs. DNA-DNA substrates, previous work by Bohlayer and DeStefano (2006) 
has demonstrated that tighter binding may be attributed to a short, 5 base pair RNA-
DNA hybrid region, where positioning of the polymerase active site of HIV-RT over 
this region yields optimal binding that is ~20-fold more stable binding than for DNA-
DNA (see Figure 7 for schematic of this interaction).  This template with only a 5-nt 
region of RNA bound as tightly as a homogenous RNA template, suggesting that all 
interactions leading to tighter binding of RNA-DNA reside in this region.  In this 
study, we attempt to expand upon these initial findings by modifying the short, 5 base 
pair RNA-DNA hybrid region in an effort to determine what conditions are both 
necessary and sufficient to confer tighter binding of HIV-RT to RNA-DNA vs. DNA-














Figure 7.  Schematic representation of a DNA-RNA primer:template hybrid.  Illustrated is 
the DNA primer (top, blue rectangle) hybridized to the D15R5D30 template.  DNA bases are 
indicated in blue; RNA bases are indicated in red.  Refer to results section(s) for definitions 

















2.2 Materials and Methods 
 
 2.2.1 Materials 
 Custom oligonucleotides were from Integrated DNA Technologies.  Plasmid 
clone for wild-type HIV-RT (type HXB2) was a kind gift from Dr Michael Parniak 
(University of Pittsburgh), and was prepared and purified as described (27).  T4 
polynucleotide kinase (PNK) was purchased from New England Biolabs.  PCR grade 
dNTPs were purchased from Roche Applied Sciences.  G-25 spin columns were from 
Harvard Apparatus.  Radiolabeled nucleotides were from Perkin-Elmer.  All 
additional reagents were purchased from Sigma Aldrich, Fisher Scientific or VWR. 
 
2.2.2 Preparation of Radiolabeled DNA Primer Strands 
 Twenty-five picomoles (pmol) of DNA (31–35 nt in length) was 5´-32P-
endlabeled using PNK.  The labeling reaction was performed at 37ºC for 30 min, as 
per the manufacturer’s protocol.  Reactions were shifted to 70ºC for 15 min in order 
to heat inactivate the PNK.  The DNA was then centrifuged on a Sephadex G-25 
column in order to remove any excess radiolabeled nucleotide. 
 
 2.2.3 Preparation of RNA-DNA and DNA-DNA Hybrids 
 Hybrids were prepared by mixing 2 pmol of 5´-32P-labeled DNA from above 
and 2 pmol of 50-nt template (see ‘Results’ sections for full list of template 
sequences) in 15 µl of buffer containing 50 mM Tris-HCl, pH=8, 80 mM KCl, 1 mM 
dithiothreitol (DTT), and 0.1 mM EDTA pH=8.  Reactions were placed at 80ºC for 5 
24 
min and then allowed to slow cool to room temperature prior to uses. 
 
 2.2.4 Determination of Dissociation Rate Constants by Primer Extension 
 HIV-RT (20 nM) was preincubated with hybrids (20 nM) in 42 µl of buffer 
containing 50 mM Tris–HCl, pH=8, 80 mM KCl, 2 mM MgCl2 and 1 mM DTT for 3 
min at room temperature.  After preincubation, 8 µl of trap supplement in the same 
buffer containing heparin sulfate (final concentration 2 µg/µl) was added to each 
reaction.  The purpose of this supplement was to bind and sequester enzyme that had 
dissociated from substrates.  Following trap addition, 5 µl aliquots were removed at 
15s (2s, 5s and 10s, time points were also taken of substrate S2P33-D50), 30s, 1m, 
1.5m, 2m, 2.5m, 3m and 4m or 15s, 1m, 2m, 4m, 8m and 16m for DNA- or RNA-
containing templates, respectively, and added to a tube containing 1 ml of dNTP 
supplement in reaction buffer plus dNTPs (100 µM final concentration).  Tubes were 
incubated at room temperature for 2 min., then terminated by the addition of 6 µl of 
2X formamide gel loading buffer (90% formamide, 20 mM EDTA, pH=8.0, 0.25% 
xylene cyanol and bromophenol blue).  
A trap control in which RT was mixed with the heparin trap and dNTPs prior 
to substrate addition and a full extension control in which trap was excluded were 
also performed and incubated for 10 min. prior to 2X formamide gel loading buffer 
addition.  Since the rate of dissociation for enzyme–nucleic acid substrate complexes 
is slow in comparison to the rate of polymerization (45,59), the amount of HIV-RT 
bound at the initiation of each reaction can be analyzed by measuring the amount of 
primer extension.  A t=0 sample was performed by mixing 1 µl of heparin trap 
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supplement and 1 µl of dNTP supplement together and adding this to 4 µl of the 
reaction + RT preincubation mix (see above).  After 2 min., 6 µl of 2X gel loading 
buffer was added to the sample.  All samples were subsequently loaded onto a 12% 
polyacrylamide/7M urea sequencing gel and subjected to electrophoresis as 
previously described (62). 
 
2.2.5 Determination of Equilibrium Dissociation Constants (Kd) by Primer 
Extension 
HIV-RT (0, 0.5, 1, 2, 3, 4, 6 and 8 nM) was preincubated with hybrids (2 nM) 
in 8 µl of buffer containing 50 mM Tris–HCl, pH=8, 80 mM KCl, 2 mM MgCl2 and 1 
mM DTT for 3 minutes at room temperature.  After preincubation, 2 µl of trap 
supplement in the same buffer containing dNTPs (final concentration 100 µM) and 
heparin sulfate (final concentration 2 µg/µl) was added to each reaction.  The purpose 
of this supplement was to bind and sequester enzyme that had dissociated from 
substrate.  Tubes were incubated at room temperature for 2 min, then terminated by 
the addition of 10 ml of 2X formamide gel loading buffer.  A trap control and full 
extension control were performed as described above for the koff determinations.  
Samples were processed as described for the koff determinations.   
 
2.2.6 Visualization and Quantification of Primer Extension 
In order to visualize and quantify primer extension, dried polyacrylamide gels 
were processed on an FLA-5100 or FLA-7000 phosphoimager from Fujifilm Life 
Sciences.  Dissociation rate constants (koff values) were obtained by fitting data to a 
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nonlinear least-squares equation for single, exponential decay [f(x) =ae–bx, where a is 
the y-intercept at time zero and b is the dissociation rate] using Sigma Plot (Jandel 
Corp.).  Data collected from time, t=0 was not included in this calculation, as aberrant 
decreases in primer extension were routinely observed between this and the next 
measured time point for some substrates (8).  Calculation of equilibrium dissociation 
constants (Kd) was determined from graphs of the concentration of extended primer 
versus concentration of RT by nonlinear least square fit to the quadratic equation: 
[ED]= 0.5* ([E]t + [D]t + Kd) - 0.5(([E]t + [D]t + Kd)2 – 4[E]t[D]t)1/2, where [E]t is 
the total enzyme concentration and [D]t is the total hybrid concentration (40).  
Experiments were generally repeated two to four times and averages +/– standard 
deviations are reported in Table 1. 
Note that this approach actually yields an ‘apparent Kd’ value, as it is 
dependent on a secondary measurement (polymerase extension) to assess binding.  
This would be a concern if there were secondary binding sites on the substrates that 
could strongly compete with the 3´recessed terminus for RT, or if a substantial 
proportion of RT interactions with the 3´ terminus were nonproductive with RT 
dissociating before incorporating nucleotides.  Each of these concerns is of very low 









 2.3.1 RNA-DNA and DNA-DNA Substrates Used to Test HIV-RT Binding 
 In previous work, we showed that RT dissociated ~20 times more slowly from 
a 33-nt DNA hybridized to a 50-nt RNA template (P33-R50, see Figure 8) as 
compared to the same DNA hybridized to a homologous DNA template (P33-D50). 
Progressively reducing the amount of RNA in the template strand showed that only 5 
nt of RNA were required for strong binding, as a chimeric template composed of (5´–
3´) 15 bases of DNA followed by 5 bases of RNA then 30 of DNA (P33-D15R5D30) 
bound to RT with even greater stably than P33-R50 (8).  In addition, positioning of 
the 3´ terminus of the shorter DNA (P33) was shown to be pivotal to tight binding, as 
substrates in which the 5-nt RNA–DNA hybrid region were not positioned over the 
recessed 3´ terminus of the DNA dissociated essentially like a homologous DNA 
template.  We therefore concluded that positioning of the 3´ terminus directly over the 
short, 5-bp region of RNA–DNA was both necessary and sufficient for mimicking the 















            
      P33-D50         P33-R50 
 
Figure 8. Autoradiograms of half-life binding experiments with primer 33 bound to  
50-mer DNA or RNA templates.  Full extension products are indicated by an arrow and are 
quantified in order to determined koff rates (see table 1).  All experiments are completed using 
wild-type HIV-RT.  Lanes 1 and 2 illustrate a ‘no enzyme’ and ‘trap’ control, respectively, 
which are designed to represent a negative control and a control to test the effectiveness of 
the heparin or poly(rA)-oligo(dT) trap supplement used in each assay (see section D.2.3).  
The latter control is prepared by first mixing enzyme, trap, and dNTPs and then introducing 
substrate.  Samples are incubated for a time equal to the longest time point on the gel.  Lane 3 
is a full extension control in which enzyme was incubated with each substrate as in the trap 
control reaction except the trap was omitted to allow all of the bound primer to be extended.  
Time points for 4-minute time course experiments are: 0, 15s, 30s, 1m, 1.5m, 2m, 3m, 4m.  









Time D50: (0-4m) 
Time R50: (0-16m) 
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Note that the previous experiments were conducted using the RNase H minus 
HIV-RT mutant, E478>Q, in the presence of Mg2+, or wild-type HIV-RT in the 
absence of Mg2+.  This was required since it is not possible to accurately measure off-
rates on an RNA–DNA hybrid with wild-type RT in the presence of Mg2+ due to 
RNase H activity. Based on its nearly equivalent binding to DNA–DNA substrates in 
the presence of 4-6 mM Mg2+ and DNA synthetic properties essentially identical to 
wild-type RT, E478>Q was considered a good model for the wild-type enzyme (16).  
Although RT substrate interactions in the absence of Mg2+ are considerably less 
stable than in its presence, the same trend was observed using wild-type HIV-RT in 
the absence of Mg2+, with tight binding equivalent to a complete RNA template 
requiring just the properly positioned 5-bp hybrid region (8).   
To examine this 5-bp region more closely, we proposed several changes.  
These included shortening the region and converting each base to DNA, as well as 














Figure 9. Sequence and configuration of nucleic acid substrates. (A) Representative 
sequences of the short DNA (top stand, denoted ‘P33’ for ‘Primer’ 33 nt) and long (DNA, or 
RNA–DNA chimera) strands are shown.  Five different short DNA strands that shared a 
common 5´-end were used.  There lengths were 31, 32, 33, 34 and 35.  Only the 33-nt strand 
that was used for most substrates is shown.  In order to illustrate the nomenclature used in the 
text, the shorter DNA is placed over the complementary bases of three of the several different 
template strands that were used.  The templates were all 50 nucleotides and consisted of 
either homogeneous DNA or RNA, or chimeras with both DNA and RNA.  RNA nucleotides 
are underlined on the templates.  Duplex substrates were named based on the short DNA and 
template used with the following nomenclature as an example: P33-D18R1(–4)D31.  This 
substrate had the 33 nt DNA hybridized to a template strand where the first 18 5´ nt were 
DNA, followed by a single RNA nucleotide, then 31 DNA nucleotides.  The -4 in parentheses 
indicates the position of the single RNA nucleotide relative to the 3´ terminus of P33 with the 
template nucleotide hybridized to the 3´ terminal base being designated as -1.  This basic 
nomenclature was used for all substrates described in the text.  (B) A second duplex with a 
different sequence that was used in experiments is shown.  These substrates are designated 











Given that these substrates are not cleaved by RT’s RNase H activity, most 
experiments were conducted in the presence of 2 mM Mg2+ and 80 mM KCl (as 
discussed above), using wild-type enzyme to more closely approximate physiological 
conditions.  Results from these experiments are presented below. 
 
2.3.2 RT Dissociates from Templates with Just Two RNA Nucleotides at a 
Rate Similar to a Complete RNA Template and Even a Single RNA 
Nucleotide at the -4 Position Results in a Dissociation Rate Much Slower than 
a Complete DNA Template 
To determine if all five bases of the RNA–DNA hybrid region noted above 
were required for slow dissociation of RT, we generated a series of chimeric 
substrates containing one to five of the RNA nucleotides.  These templates 
(D15R5D30; also D15R4D31, D15R3D32, D15R2D33 and D15R1D34) were 
hybridized to the P33 DNA and the koff of RT from each duplex was measured.  DNA 
P33 is designed to position the five-base RNA region of D15R5D30 in the 
polymerase domain of RT with the 5´ most RNA base bound to the 3´ terminal base 
of P33.  Reverse transcriptase dissociated from the P33-D15R5D30 substrate ~38 
times more slowly than to a homologous DNA template (P33-D50).  Replacement of 
the fifth nucleotide (–5 position relative to the recessed 3´ terminus of P33) with a 
DNA base resulted in a small but insignificant increase in the off-rate under the 
conditions used (Table 2, compare P33-D15R5D30 to P33-D15R4D31).  
 




Table 2. Dissociation rate constants (koff) and equilibrium dissociation constants (Kd) for RT-
substrate complexes 
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 In contrast, the koff value increased ~4-fold when the -4 and -5 bases were 
replaced by DNA (P33-D15R3D32).  A further, small but insignificant increase was 
observed when the -3, -4, and -5 nt were replaced (D15R2D33), while a substrate in 
which only the -1 nt was RNA (P33-D15R1D34) exhibited another 2–3-fold increase 
in koff.  From these results, it was clear that only a 4-bp RNA–DNA region was 
required for strong binding and that even a single RNA–DNA base pair at the -1 
position conferred slower dissociation (~2–3-fold) as compared to a complete DNA–
DNA duplex (P33-D50). 
To further test the role of each of the four RNA bases at positions -1, -2, -3 
and -4 in binding, chimeric templates containing a single RNA nucleotide at each of 
these positions were constructed.  All were hybridized to the P33 DNA and koff was 
measured for each.  RT dissociated from the substrate with a single RNA base at 
position -3 (P33-D17R1(–3)D32) at approximately the same rate as the P33-D15R1(–
1)D34 template, suggesting that both the -1 and -3 position nucleotides confer a 
modest increase in binding stability over DNA.  In contrast, RT dissociated from the 
P33-D16R1(-2)D33 substrate ~3 times more slowly than the -1 and -3 substrates.  
Finally, RT dissociated from the P33-D18R1(-4)D31 substrate ~2 times more slowly 
than the -2 substrate and approximately twice as fast as the substrate containing all 






Figure 10. Panels for dissociation rate constants (koff).  Representative assays are shown to 
illustrate how dissociation rate constants were determined.  Primer labeled with 32P at the 5´-
end was used in the assays.  The level of primer extension over time was quantified using a 
phosphoimager as described in ‘Materials and Methods’ section and these values were plotted 
to determine koff.  Time points used for the P33-D50 assay were 0, 15 s, 30 s, 1 m, 1.5 m, 2 m, 
2.5 m, 3m and 4 m, while for all other assays time points were 0, 30 s, 1 m, 2 m, 4 m, 8m and 
16 m. Lane A in each panel shows a reaction in the absence of enzyme.  Lane B shows a 
control reaction to test the effectiveness of the heparin trap (see ‘Materials and Methods’ 
section). In this reaction, the enzyme was mixed with the trap and the mixture was added to 
the substrate in the presence of dNTPs and divalent cation and incubated for 10 min. before 
termination.  Lane C shows a full extension control in which enzyme was incubated with the 
substrate as in the trap control reaction except trap was omitted to allow all the bound primer 









Since the -2 and -4 positions appeared to be most important to the slow 
dissociation of RT from RNA–DNA, a template containing both RNA nucleotides 
(D16R1(–2)D1R1(–4)D31) was constructed and tested.  Dissociation of RT from a 
substrate with this template (P33-D16R1(–2)D1R1(–4)D31) was very slow, such that 
the off-rate was difficult to measure under the conditions used (data not shown).  
Taken together, these results indicate that a single RNA nucleotide at the -4 position 
results in RT dissociating ~14 times more slowly than from a complete DNA strand 
(D50), while RT binds to templates with both the -2 and -4 RNA nucleotides even 
more stably than a complete RNA strand [based on D15R5D30 binding even more 
stably to RT than a complete RNA strand (see above)]. 
 
2.3.3 A Uridine Residue at the -4 Position Promotes More Stable HIV-RT 
Binding than Other RNA Nucleotides 
It was interesting that, in addition to the importance of the -4 RNA nucleotide 
(P33-D18R1(–4)D31), the -2 position (P33-D16R1(–2)D33) also had a significant 
effect on RT dissociation.  Further, both of these bases were uridines, suggesting that 
there may be some base preference for promoting stable RT binding.  To test this 
theory, the U at the -4 position was changed to A, G and C with the corresponding 
base in the P33 DNA also changed to maintain complementarity.  Dissociation rates 
from these substrates were measured, and RT was noted to dissociate more rapidly 
from all of them (Table 2).   
The koff was increased ~3-fold when the U was replaced by an A (P33-
D18R1(-4U>A)D31) or a G (P33-D18R1(-4U>G)D31) and ~2-fold for a C (P33-
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D18R1(-4U>C)D31) replacement.  In contrast, changing the -2 position from a U to 
either an A (P33-D16R1(-2U>A)D33) or a C (P33-D16R1(-2U>C)D33) did not 
significantly change the koff (data not shown).  These results indicate that binding to 
RT is most stable if the single RNA nucleotide in the template is a uridine at the -4 
position, though it is also important to note that other RNA residues at this position 
lead to koff values that were several fold lower than a homogenous DNA. 
 
2.3.4 Moving the -4 Uridine Residue to Different Positions Relative to the 
DNA 3´ Recessed Terminus Increased HIV-RT’s Dissociation Rate, 
Confirming the Importance of the -4 Position in the RNA 
The above experiments do not rule out the possibility that the specific 
sequence context of the -4 nt in this particular substrate, rather than the position 
relative to the 3´ recessed terminus, is the major determinant for slow dissociation.  
To test this further, the position of the -4 uridine relative to the DNA 3´ terminus was 
shifted using DNAs of various lengths.  Oligonucleotides P31, P32, P34 and P35 
place the single RNA base in D18R1(-4)D31 at the -2, -3, -5 and -6 position, 
respectively, relative to the 3´ terminus. These substrates all showed reduced binding 
to RT as compared to P33-D18R1(-4)D31.  Placing the RNA base in the -5 position 
(P34-D18R1(-4>-5)D31) was least detrimental, resulting in a ~2-fold increase in koff, 
while the -2 (P31-D18R1(-4>-2)D31), -3 (P32-D18R1(-4>-3)D31) and -6 (P35-
D18R1(-4>-6)D31) positions increased koff ~5-, 10- and 6-fold, respectively.  The 
above results illustrate the importance of an RNA nucleotide at the -4 position for 
stable binding of RT.  In addition, they show that moving this position further away 
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from the recessed 3´ DNA terminus, as in P34-D18R1(-4>-5)D31, is less unfavorable 
than moving it nearer. 
 
2.3.5 The 2´-Hydroxyl Groups on the RNA Nucleotides are not Required to 
Stabilize Binding of HIV-RT 
As was noted in the introduction, several interactions between 2´-hydroxyl 
groups and RT amino acids have been proposed based on the crystal structure of 
HIV-RT bound to RNA–DNA (63).  Many of these are hydrogen bonds involving the 
hydroxyl at the 2´ position of the RNA nucleotide.  To determine if the 2´-hydroxyl 
was pivotal for stabilizing RT binding on RNA–DNA, modified versions of 
D15R5D30 and D18R1(–4)D31 in which the RNA nucleotide hydroxyls were 
converted to 2´-O-methyls were tested (P33-D15methylR5D30 and P33-
D18methylR1(–4)D31).  In both cases, RT koff values were similar compared to the 
templates with 2´-hydroxyl RNA bases (Table 2), indicating that the 2´-hydroxyls do 
not play a role in stabilizing binding. 
 
2.3.6 Slower Dissociation of HIV-RT from RNA-DNA is not Dependent 
upon Sequence 
Both the previous work (8) and the work described above were completed 
utilizing a single template sequence.  It was possible, therefore, that some of the 
findings could be unique to the particular sequence used.  To address this concern, a 
substrate with a different sequence was constructed and analyzed [Figure 9; sequence 
2 (S2)].  Although the sequence design was essentially arbitrary, uridine was 
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intentionally excluded from the -2 and -4 positions.  By subsequently converting the -
4 base to uridine, we could then test whether the conclusions from the previous 
substrate, which indicated a strong preference for uridine at the -4 position in stable 
binding to RT, were upheld under these new conditions.  Overall, results indicated 
that RT dissociated much faster from this new sequence (Table 2).  
For instance, a ~10-fold increase in the koff value was observed for the 
complete DNA template compared to the previous sequence (i.e. S2P33-D50 vs. P33-
D50).  Additionally, the five RNA nucleotide version of this template (S2P33-
D15R5D30), while dissociating much more slowly from RT than the complete DNA-
DNA duplex (93-fold), still showed a ~5-fold higher koff than the previous sequence.  
A substrate with only one RNA nucleotide at the -4 position (S2P33-D18R1(-4)D31) 
also showed an ~4-fold increase in koff compared to S2P33-D15R5D30, though it still 
bound much more stably than a complete DNA–DNA duplex (~17-fold).   
Consistent with a preference for U at the ~4 position, converting the -4 
position from an adenine to a uridine and the corresponding base in the 33-mer DNA 
to an A resulted in ~2-fold decrease in koff (S2P33-D18R1(–4A>U)D31 compared to 
S2P33-D18R1(–4)D31).  Including RNA bases at both the -2 and the -4 positions 
resulted in a koff value that was essentially the same as the substrate with 5 nt of RNA 
(compare S2P33-D15R5D30 and S2P33-D16R1(–2)D1R1(–4)D31), just as it did for 
the first sequence tested.  Overall, results with the second template support a role for 
the -2 and -4 nucleotides, as well as the preference for U over other bases at the -4 
position, in promoting stable binding of HIV-RT to RNA–DNA. 
While this is the case, they also highlight distinct sequence-dependent 
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differences. This was the case in our previous work as well, where various primers 
were used to position RT at different locations along a 50-nt template identical to the 
first template used in this work.  Off-rates differed several-fold and were dependent 
on the position of the primer relative to the template termini as well as the particular 
sequence to which the primer was bound.  Specifically, the difference in off-rates for 
RNA–DNA versus DNA–DNA duplexes varied from as little as 7-fold to as much as 
90-fold more stable binding to the former as compared to the latter (8). 
 
2.3.7 The Equilibrium Dissociation Constant (Kd) for HIV-RT is Nearly the 
Same for RNA-DNA and DNA-DNA Despite Large Differences in koff 
Since the equilibrium dissociation constant is dependent on the on- and off-
rate (Kd=koff/kon), the lower koff values for the RNA–DNA heteroduplex compared to 
DNA–DNA homoduplex would imply a higher affinity for the former.  This would be 
reflected in a lower Kd for the heteroduplexes providing that no change in the on-rate 
had occurred.  Assays were performed to measure the Kd of RT for P33-D50, P33-
D15R5D30, P33-D15methylR5D30, P33-D16R1(–2)D33 and P33-D15R1(–1)D34.  
Surprisingly, RT had similar Kd values for all five substrates (Table 2 and Figure 11), 
even though dissociation was 38 and 30 times faster from P33-D50 than P33-
D15R5D30 and P33-D15methylR5D30, respectively, and 8.2 and 2.2 times faster 















Figure 11. Representative assays are shown to illustrate how dissociation equilibrium 
constants were determined.  Panels are labeled at the top with the primer-template that was 
used in the assay.  The concentration of RT (nM) is noted above each lane.  Lane A in each 
panel shows a reaction in the absence of enzyme.  Lane B shows a control reaction to test the 
effectiveness of the heparin trap (see ‘Materials and Methods’ section).  In this reaction, the 
enzyme was mixed with the trap and the mixture was added to the substrate in the presence of 
dNTPs and divalent cation and incubated for 10 min. before termination.  Lane C shows a full 
extension control in which enzyme was incubated with the substrate as in the trap control 


















Chapter 3: Analysis of the Preferential Binding of MuLV-RT 








 3.1.1 Moloney Murine Leukemia Virus Reverse Transcriptase (MuLV-RT) 
 A member of the gammaretroviral genus, moloney murine leukemia virus 
(MuLV) is structurally similar to HIV-1 and, as its name suggests, is responsible for 
the induction of non-B, non-T cell leukemia in susceptible mice (49).  Much like its 
HIV-1 counterpart, MuLV-RT consists of finger, palm, and thumb subdomains 
localized centrally to the polymerase active site, as well as an RNase H domain.  
While this is the case, the enzyme itself is a structurally distinct monomer comprised 
of approximately 671 amino acids (14).  Studies, such as the ones conducted by Coté 
and Roth (2008) and Fuentes et al. (1996), have explored the effects of these 
structural variations on substrate binding, noting that such variations may be 
necessary in order to accommodate the full array of activities carried out by MuLV-
RT and that they do not significantly affect RT-substrate interactions and extension.  
Fuentes and colleagues also demonstrated an increased preference of MuLV-RT for 
RNA rather than for DNA oligonucleotides bound to DNA templates.  This result is 
interesting in light of previous evidence that implicated HIV-RT as having a higher 




3.1.2 Avian Myeloblastosis Virus Reverse Transcriptase (AMV-RT) 
Avian myeloblastosis virus (AMV), a major etiological agent in the 
development of acute myeloblastic leukemia and other, related carcinomas, is unique, 
among the other viruses discussed here, in that it is defective in the absence of 
myeloblastosis-associated helper virus (MAV) (64).  While this is the case, 
replication in this virus proceeds in similar fashion to that of other retroviral species, 
ultimately resulting in the production of proviral double-stranded DNA that can 
subsequently be integrated into the host genome.  Though concerns regarding the 
purity of AMV-RT stocks continue to proliferate [given the necessity of a helper 
virus], this feature and the relative ease by which one can generate AMV-RT allows 
AMV to remain as one of the major sources of avian reverse transcriptase available 
(39, 56). 
Upon closer examination of AMV-RT, it has been shown that, much like 
HIV-RT, this enzyme is a heterodimer comprised, in this case, of both an α (65 kDa) 
and β (95 kDa) subunit that share a high degree of structural similarity.  Interestingly, 
it has also been shown that the α subunit possesses both the RNA-dependent DNA 
polymerase and RNase H activities common to retroviral reverse transcriptases, while 
the β subunit remains inactive.  This arrangement does not seem to have any 
substantial effect on enzymatic activity (4, 56).  Further studies have corroborated this 
claim, suggesting that the processivity [the average number of nucleotides added by 
the polymerase per association/dissociation with the template] of AMV-RT is higher 
than that of other reverse transcriptases, such as those derived from mice, and that, 
while incorporating a relatively large number of incorrectly paired bases while 
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carrying out the replication process, DNA synthesis on both RNA and DNA 























3.2 Materials and Methods 
Experimental and visualization procedures were as noted above in section 2.2, 
with the exception that koff and Kd reactions with AMV- or MuLV-RT on both DNA–
DNA and RNA–DNA duplexes were run over a 16-min. time course and the trap was 
poly(rA)-oligo(dT20) [8:1 rA:dT (w:w), final concentration 0.4 µg/µl] instead of 
heparin for AMV-RT.  Additionally, magnesium was omitted from the preincubations 
in some experiments, which were conducted with 20 rather than 80 mM KCl.  With 
respect to the Kd assay, the analyzed enzyme concentrations for AMV-RT were, in 
















3.3 AMV-RT and MuLV-RT Show More Modest Preference for Binding to RNA-DNA 
versus DNA-DNA 
 In order to determine if the behavior of HIV-RT is typical for other reverse 
transcriptases, the binding of AMV- and MuLV-RTs on various substrates was also 
examined.  With regard to P33-D50, both AMV-RT and MuLV-RT bound 
considerably more stably than HIV-RT (~9- and 6-fold, respectively, Table 2).  Like 
HIV-RT, AMV-RT bound even more stably to P33-D15R5D30 [none of the enzyme 
used here showed significant RNase H-directed cleavage of the substrate (data not 
shown)].  Binding was so tight that no consistently measurable dissociation was 
detected under the conditions used.  In contrast, MuLV-RT bound this substrate only 
~2-fold more stably than the DNA–DNA.  Also consistent with HIV-RT, Kd values 
for AMV-RT on P33-D50 and P33-D15R5D30 were similar despite the large koff 
difference.   
It is important to note that the D15R5D30 template was optimized for binding 
to HIV-RT using the HIV-RT E478>Q mutated RT (8).  It is possible, therefore, that 
the 5-nt RNA region may not be ideal for the other enzymes tested here.  To further 
evaluate duplex binding properties, each enzyme was additionally examined on P33-
D50 and P33-R50.  These experiments were carried out in the absence of Mg2+ in the 
dissociation phase in order to prevent cleavage of P33-R50.  The KCl concentration 
was lowered to 20 mM to compensate for the lower binding stability observed in the 
absence of Mg2+ (20).  Under these conditions, all the enzymes bound more stably to 
the RNA–DNA duplex, however, HIV-RT bound 27-fold more stably, while the other 
enzyme showed only ~2-fold better binding to RNA–DNA. 
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4.1 Slower Dissociation of HIV-RT from RNA-DNA versus DNA-DNA does not 
require 2´-Hydroxyls and is Dependent on the RNA Nucleotides at the -2 and -4 
Positions 
Here, we show that HIV-RT’s several fold slower dissociation from binary 
complexes with RNA–DNA versus DNA–DNA requires just two RNA nucleotides 
(–2 and -4 positions) of the RNA strand and does not require 2´-hydroxyl groups.  
Similar Kd values for all duplexes tested (see appropriate results sections) suggested 
that changes in kon that were approximately proportional to the changes in koff for the 
various substrates were occurring (see below).  The differential stability of the binary 
complexes could be especially relevant for RT binding to RNA fragments for 
degradation (see below).   
Replacement of 2´-hydroxyl groups on pivotal RNA nucleotides with 2´-O -
methyl groups had no effect on RT’s koff or Kd for RNA-DNA hybrids (see section 
2.3.5).  Structural data suggest that the important -2 nucleotide interacts with glutamic 
acid 89 (E89) of RT by a hydrogen bond to the 2´-hydroxyl group, while an 
interaction between the pivotal -4 base and isoleucine 94 (I94) is also proposed (63).  
While the 2´-O-methyl modification would have abrogated the E89 interaction to -2, 
it is unclear if the I94 interaction would have been affected.  There is always the 
possibility that novel interactions that promote stable binding to RT occur with 2´-O-
methyl groups.  However, the koff values were essentially identical for the 2´-O-
methyl and 2´-hydroxyl versions of the substrates containing the 5-bp RNA–DNA 
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hybrid region (compare P33-D15R5D30 and P33-D15methylR5D30) and the 
substrate with a single RNA at the -4 position (compare P33-D18R1(–4)D31 and 
P33-D18methylR1(–4)D31).   
The Kd values were also the same for methylated and non-methylated versions 
of the 5-bp RNA–DNA substrates.  It is therefore unlikely that novel interactions with 
2´-O-methyls would have influenced RT binding to the same extent as 2´-hydroxyl 
interactions.  Taken together, these results strongly suggest that amino acid 
interactions with RNA 2´-hydroxyls do not play a major role in stabilizing the 
binding of RT to RNA–DNA. 
 
4.2 The H-Form versus B-Form Structure of RNA-DNA and DNA-DNA Hybrids, 
Respectively, is the Most Likely Explanation for HIV-RT’s Slower Dissociation from 
RNA-DNA 
 The results presented above provide strong evidence in favor of an alternative 
explanation for why HIV-RT binds more stably to RNA templates; however, there is 
no clear indication as to what this alternative is.  Some possibilities include: (i) the 
proposed H-form structure of RNA–DNA hybrids is more conducive to stable 
binding than the B-form structure of DNA–DNA; (2) differences in ‘flexibility’ 
between DNA–DNA and RNA–DNA hybrids (53) allow the latter to more easily 
conform to RT’s angled binding cleft; and (3) RT binds stably to the chimeric RNA–
DNA substrates tested here not because they ‘mimic’ RNA–DNA but because they 
induce a bend or kink in the substrate that is favorable to RT binding.  The last 
possibility was largely discredited in a previous report with chimeric nucleic acids 
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(8).  Of the remaining two, we favor the first.   
The first possibility would seem to be weakened by the fact that RT’s slow 
dissociation from RNA can be mimicked by duplexes with only short stretches of 
RNA–DNA.  Duplexes with 4- and 5-nt RNA–DNA hybrid regions may take on 
some H-form qualities over the short stretch, but this seems less likely for the 
duplexes that had only one or two RNA nucleotides.  Still, these individual 
nucleotides may make it easier for the substrate to transition to a structure that 
conforms to RT’s binding cleft.  Pertinent to this was the preference for uridine at the 
-4 position, which may also make the transition easier. 
Crystal structures of RT bound to DNA–DNA and RNA–DNA duplexes show 
that the ~4-bp hybrid region proximal to RT’s polymerase active site has a structure 
similar, but not identical, to A-form nucleic acid (the structure formed by RNA-RNA 
hybrids), followed by a ~40º bend that occurs over 4 bp.  The remaining duplex in the 
binding cleft is closer to B-form, similar to normal DNA–DNA (63,43).  
Interestingly, the A-form portion of the duplex is nearly the same size as the 4–5-bp 
RNA–DNA hybrid region required for maximal binding stability in these experiments 
and is positioned in the exact same region as the A-form DNA–DNA or RNA–DNA 
in the crystals.  Although RNA–DNA is H-form rather than A-form, H-form, a 
‘hybrid’ of A- and B-forms, is closer in structure to A-form than B-form is (38). 
Therefore, RT may have to contort DNA–DNA hybrids more in order to get them to 




4.3 Both On- and Off-Rates appear to be Different for RNA-DNA versus DNA-DNA 
Duplexes 
 Differences in koff values between RNA–DNA and DNA–DNA bound to RT 
in binary complexes were not reflected in Kd values, which were similar for those 
duplexes that were tested (see results sections above).  These findings are consistent 
with other reports that show similar Kd values, despite different off-rates, for RT 
binding to DNA–DNA and RNA–DNA (81,45) and minus strand initiation 
complexes with tRNALys, 3-RNA versus the same RNA primed with an 18-nt DNA 
that is homologous to the last 18 3´ nt of tRNALys, 3 (48).  In that case, although Kd 
values differed by only ~2-fold, the off-rate of the DNA-primed complex was ~200 
times slower.  The Kd values reported for both duplex types analyzed here are also 
similar in magnitude to those reported by others in comparative studies, though the 
relative difference between koff values for RNA–DNA and DNA–DNA are, in 
general, greater than previously reported (81,45, 80).  It is possible that this difference 
could be sequence specific.  Likewise, such a difference may also stem from the very 
tight binding of RT to the chimeric substrate (P33-D15R5D30), which bound RT 
about ~2.5-fold more stably than the substrate with a complete RNA strand in our 
previous experiments (8). 
Overall the similar Kd, but vastly different koff, values imply large differences 
in the kon for RNA–DNA and DNA–DNA.  However, for all the substrates tested in 
the current report to converge to a similar Kd value, approximately proportional 
changes in the on-rates, which compensate for the widely differing off-rates, must be 
invoked.  This suggests that achieving a more stable binding state requires additional 
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time or steps that are reflected in a slower on-rate.  Apparently, this also results in an 
approximately equal decrease in the off-rate.  In comparing DNA-primed RNA and 
DNA templates, Whörl et al. (28) noted a slow isomerization step that occurred after 
initial binding of RT to the substrate.  The RNA–DNA substrate showed a greater 
propensity to undergo the isomerization step and form a ‘productive’ complex.  The 
authors also suggest, as we do, that structural differences between the duplexes make 
it easier for RNA–DNA to conform to the RT binding cleft.   
Since Kd values are similar for both duplex types, any bound state of RT, 
including those that have or have not undergone isomerization and those with more or 
less stable isomerized states, must quickly convert to a catalytically competent form 
upon ternary complex formation.  This transition occurs without significant 
dissociation of RT from the substrate, leading to similar Kd values for each duplex 
type. This is consistent with biochemical analysis indicating that dNTP binding 
stabilizes the RT-substrate complex (45, 75, 47).  In turn, the biochemical data are 
consistent with crystal structures of RT in binary and ternary complexes with DNA–
DNA duplexes.  Nucleotide binding leads to significant closure of the gap between 
the finger and thumb domains as they close down on the primer-template and 
stabilize substrate binding (41). 
 
4.4 Structural Differences between HIV-, AMV-, and MuLV-RT May Explain 
Differences in Duplex Binding 
 Results indicated that all tested RTs exhibited a preference for binding RNA–
DNA, although clear quantitative differences existed between each.  A comparison of 
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RT binding to P33-D50 versus P33-D15R5D30 in the presence of Mg2+ and to P33-
D50 versus P33-R50 in its absence revealed that HIV-RT showed the most difference 
between the different duplexes, followed by AMV-RT, and, finally, by MuLV-RT, 
which showed the least difference.  It is notable that MuLV-RT is the only 
monomeric enzyme in this group, while HIV- and AMV-RTs are both heterodimers 
(74).  Perhaps even more relevant are the extensive differences observed in crystal 
structures of MuLV-RT compared to HIV-RT (14,17).  The single available crystal 
structure of the MuLV-RT complete monomer suggests that the duplex trajectory is 
significantly different compared to HIV-RT as are the positions of the finger and 
thumb domain.  Computer modeling also suggests significant differences in how the 
template bends while traversing through the binding clefts of the two enzymes (14).  
Therefore, the structural explanation provided here, which relies on the B- to A-form 
transition of the duplex while bound to HIV-RT leading to more stable RNA–DNA 
binding, may not be relevant for MuLV-RT.  A crystal structure of MuLV-RT with a 



















 5.1.1 Ty3 Reverse Transcriptase (Ty3-RT) 
 Here we provide an analysis of the requirements necessary and sufficient for 
tighter binding of various retroviral RTs to RNA-DNA vs. DNA-DNA duplexes.  To 
provide a more comprehensive depiction of this interaction, we propose that future 
studies include data on non-retroviral species, such as the Saccharomyces cerevisiae 
Ty3 retrotransposon.  Though not of retroviral origin, the p55 reverse transcriptase 
from the Ty3 retrotransposon (Ty3-RT) possesses both a polymerase and RNase H 
domain and requires both a host-derived tRNA primer and its own, conserved 
polypurine tract (PPT) sequence in order to initiate (-) strand and (+) strand synthesis, 
respectively (29, 58).  Despite this apparent similarity, evidence suggests that Ty3-RT 
may be distinct in that (i) it is less active than its HIV-1 counterpart, suggesting an 
augmented level of strand displacement activity, (ii) RNase H-mediated selection and 
the release of the PPT primer is less precise than for retroviruses, and (iii) the 
interaction between the integrase protein and Ty3-RT may be more crucial for 
successful replication than in other, similar viruses (46, 54, 58, 76).  Given these 
characteristics, subsequent studies have sought to explore the interactions of Ty3-RT 
with various DNA and RNA intermediates in an effort to provide a more descriptive 
picture of how retrotransposon-based reverse transcription takes place.   
In one study by Bibillo and colleagues (2005), extension of duplex DNA and  
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DNA-RNA hybrids was examined in the presence of Ty3-RT which had undergone 
amino acid (AA) substitutions in both the polymerase and RNase H domains.  Results 
suggested that the introduction of AA sequence substitutions in the enzyme had a 
dramatic effect on both the processivity of the enzyme on the aforementioned 
substrates, as well as proper functioning of the RNase H-mediated RNA decay 
mechanism.  Interestingly, data also indicated that Ty3-RT might exploit similar 
structural motifs as HIV-RT during synthesis events.  While it has been 
acknowledged that limited information currently exists on retrotransposons of this 
nature, such findings (see also: 25) continue to provide valuable, comparative 
knowledge regarding the reverse transcription process in this species.  With regard to 
our own studies, determination of the koff and Kd values and comparison of these 
values against those of the RTs studied herein may also aid in this effort. 
 
 5.1.2 Biological Relevance for Different Binding States on DNA-DNA and 
RNA-DNA 
 In general, the ability of RT to form a stable, tight binding complex on RNA–
DNA in the absence of dNTPs may aid in carrying out RNase H cleavage of RNA 
fragments that remain bound to the template after DNA synthesis.  Since RT does not 
completely degrade the RNA genome during synthesis, secondary cleavage events are 
required to remove fragments that remain associated with the nascent DNA or to 
process important regions of the genome, such as the polypurine tract, so it can be 
used for second strand priming (24, 77-79).  The orientation of RT during secondary 
cleavage places the polymerase domain at the 5´-recessed end of the RNA fragment 
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where extension cannot occur and dNTP binding is unlikely (19, 22, 23, 55).  
Therefore, it is important for RT to be able to bind RNA–DNA stably even in the 
absence of dNTPs.  Obtaining results with Ty3-RT that suggest tighter binding of the 
enzyme to RNA vs. DNA templates or, more specifically, to conserved regions such 
as the polypurine tract, would further support this argument.   
 
 




 5.2.1 Background on Dissociation Studies of HIV-RT 
 For well over a decade, researchers have analyzed the interactions of HIV-RT 
with various primer-template substrates in an effort to provide a detailed account of 
how this enzyme binds to, processes, and dissociates from such substrates during 
replication events.  Such work has shown, for instance, that primer-template length 
and composition [RNA-DNA vs. DNA-DNA and the respective sequences of these 
hybrids], the concentration of the HIV-RT cofactor, Mg2+, the presence of the HIV-1 
nucleocapsid protein, and template secondary structure may all have a dramatic 
impact on the replication cycle and on dissociation of HIV-RT following DNA 
synthesis (33, 16, 36, 71, 72, 2; respectively).  While this is the case, the exact 
mechanism of enzymatic dissociation is not entirely known.  
Recently, Liu et al. (2008) showed that HIV-RT could shuttle between 
opposite termini of RNA-DNA and DNA-DNA duplexes, facilitating targeting of RT 
to the primer terminus for DNA polymerization and positioning of the template for 
RNA degradation, among other features.  Furthermore, RT was able to flip into the 
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polymerization orientation once it had reached the primer terminus without first 
dissociating from the template.  Such a finding is interesting, the authors argue, in 
light of HIV-RT’s relatively low-processivity level and multifunctional nature. 
 
 5.2.2 Proposed Experiments to Analyze those Requirements Necessary for 
Dissociation of HIV-RT from its Respective Template 
In an effort to block “sliding” events from occurring, custom oligonucleotides 
consisting of streptavadin-bound, biotinylated DNA and/or RNA nucleotides will be 
obtained from IDT.  Modified bases will be located either upstream, downstream, or 
both upstream and downstream from the replication initiation site so as to help 
determine which direction, if any, RT must slide in order for dissociation to occur.  
Though previous reports have demonstrated the success of such templates in 
preventing translocation events in other model systems (67-68), it is unknown 
whether or not this same mechanism will be successful in blocking HIV-RT from 
“sliding” along its respective template.  In the event that the above method is not 
sufficient to block RT trafficking, secondary structural modifications will instead be 
introduced into the template strand as a viable means by which to impede RT 




Figure 12.  Model of HIV-RT extension on a template containing a secondary structural 
modification.  (A) Radiolabeled primer is hybridized to a template containing DNA, RNA or 
both DNA and RNA.  (B) HIV-RT and dNTPs are introduced.  (C) The introduction of these 
reagents allows for primer extension by RT.  (D) Interaction of RT with template secondary 
structure causes the enzyme to pause, possibly preventing or slowing RT dissociation.  RT 










All other materials and methods are as in section 2.2.3 above. 
 
5.2.3 Discussion of Possible Outcomes 
Given previous reports (see, as example, Liu et al., 2008), as well as our own  
findings regarding the effect of primer length on RT binding (see section 2.3.4 
above), it is plausible that, in addition to its ability to traffic along primer-template 
substrates during extension and RNase H-mediated RNA degradation events, 
“sliding” along these same substrates may be necessary in order for HIV-1 reverse 
transcriptase to dissociate from the replication complex.  We have proposed to 
explore this possibility by determining the dissociation rate of HIV-RT on various 
modified substrates, as described above in section 5.2.2.  We anticipate that one of the 
following hypotheses is true: 
 
 HIV-RT will require a “sliding” mechanism in order to dissociate from its 
template (and hence structural modifications to this template will prevent or 
slow dissociation from occurring) 
 HIV-RT dissociates directly from the template without employing a “sliding” 
mechanism (in which case structural modifications should have no effect) 
 
In the case of the former, it is expected that autoradiographic and quantitative 
evidence will indicate similar levels of primer extension at each time point, as RT 
would theoretically not be able to dissociate from the template nor continue extension 
given the structural modifications imposed.  We would not expect this to happen in 
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the latter circumstance but rather would anticipate the dissociation rate to remain 
consistent with previously reported data (as discussed above).  For instance, the P33-
D50 dissociation value, as listed above, is 0.90 +/- 0.12 min-1.  If “sliding” events 
were not necessary in order for the polymerase to dissociate, we would expect a value 
similar to this.  If, on the other hand, translocation between primer-template termini 
were required, we would expect no significant quantitative difference between those 
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